{
    "id": "9169399e-bca1-4c44-9a93-886f3650e44d",
    "indications": "Methocarbamol tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.",
    "contraindications": "Methocarbamol tablets, 500 mg - Adults:\n                  Initial dosage: 3 tablets 4 times daily.\n                  Maintenance dosage: 2 tablets 4 times daily.\n                  Methocarbamol tablets: 750 mg - Adults:\n                  Initial dosage: 2 tablets 4 times daily.\n                  Maintenance dosage: 1 tablet q.4h. or 2 tablets 3 times daily.\n                  Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered.) Thereafter, the dosage can usually be reduced to approximately 4 grams a day.",
    "warningsAndPrecautions": "Methocarbamol Tablets USP, 750 mg are white in color, biconvex capsule shaped film-coated tablet, debossed with “METT” on one side and “750” on the other side. They are supplied as follows:\n                  Bottles of 30                         NDC 68788-8876-3\n                  Bottles of 60                         NDC 68788-8876-6\n                  Bottles of 90                         NDC 68788-8876-9\n                  \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].         \n                  \n                     Dispense in tight container.\n                  \n                  For more information, call Aurobindo Pharma USA, Inc.at 1-866-850-2876.\n                  Distributed by:\n                     Aurobindo Pharma USA, Inc.\n                     279 Princeton-Hightstown RoadEast Windsor, NJ 08520\n                      Manufactured by:\n                     Aurobindo Pharma Limited\n                     Hyderabad-500 032, India \n                      Revised: 08/2022\n                  \n                     Repackaged By: Preferred Pharmaceuticals Inc.",
    "adverseReactions": "Methocarbamol tablets are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.",
    "ingredients": [
        {
            "name": "Methocarbamol",
            "code": "125OD7737X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "organization": "Preferred Pharmaceuticals Inc.",
    "name": "Methocarbamol",
    "effectiveTime": "20250519"
}